| Rami Alharethi, MD | |
|
5121 S Cottonwood St, Heart Failure & Transplant, Ll1, Murray, UT 84107-5701 | |
| (801) 507-4637 | |
| Not Available |
| Full Name | Rami Alharethi |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 30 Years |
| Location | 5121 S Cottonwood St, Murray, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851306369 | NPI | - | NPPES |
| 269973 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD25823 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Intermountain Medical Center | Murray, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
The Department of Health and the Health Protection Agency have today published an updated report of the Health Effects of Climate Change in the UK .
The Department of Orthopaedic Surgery at NYU Langone Medical Center has been chosen as one of only 16 centers across the country to participate in the American Joint Replacement Registry (AJRR). The AJRR is a national, independent, not-for-profit organization created to collect key joint replacement and revision data in order to better to monitor device performance and identify underperforming processes while providing information supporting best practices in safety, cost control and advances in technology.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
Santarus, Inc., a specialty biopharmaceutical company, today announced the completion of enrollment of 510 patients in a U.S. Phase III clinical study to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis. This is the second Phase III clinical study being conducted in collaboration with Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA, as part of the budesonide MMX Phase III clinical program for U.S. registration.
Results from routine carbon monoxide (CO) testing in the breath of people attending such clinics or GP support services can alert healthcare professionals to patients who are suffering from chronic, low-level CO poisoning.
› Verified 4 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
The Department of Health and the Health Protection Agency have today published an updated report of the Health Effects of Climate Change in the UK .
The Department of Orthopaedic Surgery at NYU Langone Medical Center has been chosen as one of only 16 centers across the country to participate in the American Joint Replacement Registry (AJRR). The AJRR is a national, independent, not-for-profit organization created to collect key joint replacement and revision data in order to better to monitor device performance and identify underperforming processes while providing information supporting best practices in safety, cost control and advances in technology.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
Santarus, Inc., a specialty biopharmaceutical company, today announced the completion of enrollment of 510 patients in a U.S. Phase III clinical study to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis. This is the second Phase III clinical study being conducted in collaboration with Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA, as part of the budesonide MMX Phase III clinical program for U.S. registration.
Results from routine carbon monoxide (CO) testing in the breath of people attending such clinics or GP support services can alert healthcare professionals to patients who are suffering from chronic, low-level CO poisoning.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rami Alharethi, MD 5121 S Cottonwood St, Heart Failure & Transplant, Ll1, Murray, UT 84107-5701 Ph: () - | Rami Alharethi, MD 5121 S Cottonwood St, Heart Failure & Transplant, Ll1, Murray, UT 84107-5701 Ph: (801) 507-4637 |
News Archive
The Department of Health and the Health Protection Agency have today published an updated report of the Health Effects of Climate Change in the UK .
The Department of Orthopaedic Surgery at NYU Langone Medical Center has been chosen as one of only 16 centers across the country to participate in the American Joint Replacement Registry (AJRR). The AJRR is a national, independent, not-for-profit organization created to collect key joint replacement and revision data in order to better to monitor device performance and identify underperforming processes while providing information supporting best practices in safety, cost control and advances in technology.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
Santarus, Inc., a specialty biopharmaceutical company, today announced the completion of enrollment of 510 patients in a U.S. Phase III clinical study to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis. This is the second Phase III clinical study being conducted in collaboration with Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA, as part of the budesonide MMX Phase III clinical program for U.S. registration.
Results from routine carbon monoxide (CO) testing in the breath of people attending such clinics or GP support services can alert healthcare professionals to patients who are suffering from chronic, low-level CO poisoning.
› Verified 4 days ago
Bogdan Ciprian Anea, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: Intermountain Kidney Services Clinic, 5169 South Cottonwood Street, Suite 320, Murray, UT 84107 Phone: 801-507-2531 Fax: 801-507-2597 | |
E Dennis Genebach, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 5801 Fashion Blvd, Murray, UT 84107 Phone: 801-314-4544 | |
Dr. Samuel Morris Brown, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5121 S Cottonwood St, Murray, UT 84107 Phone: 801-507-6415 | |
Dr. Jamie Lynn Rebman, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5121 Cottonwood Rd, Suite 610, Murray, UT 84107 Phone: 801-507-3630 Fax: 801-507-3630 | |
Dr. Kia Afshar, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5169 S Cottonwood St Ste 520, Murray, UT 84107 Phone: 801-507-4701 | |
Rachel Elizabeth Hu, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5171 S Cottonwood St Ste 610, Murray, UT 84107 Phone: 801-507-3900 Fax: 801-507-3640 | |
Caroline Nebhan, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5171 S Cottonwood St Ste 610, Murray, UT 84107 Phone: 801-507-3630 |